Nonarteritic anterior ischemic optic neuropathy (NAION) is significantly associated with persistently elevated risk for stroke, independent of typical cardiovascular risk factors, a large ...
Please provide your email address to receive an email when new articles are posted on . Semaglutide was not linked to non-arteritic anterior ischemic optic neuropathy in patients with overweight or ...
Please provide your email address to receive an email when new articles are posted on . One study showed semaglutide and tirzepatide raised the risk for nonarteritic anterior ischemic optic. Another ...
For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to a study published online March 27 in JAMA ...
Semaglutide was tied to a small risk of nonarteritic anterior ischemic optic neuropathy (NAION) in adults with type 2 diabetes. The risk was more modest than previously reported. Using the specific ...
Use of once-weekly semaglutide more than doubles the risk for nonarteritic anterior ischemic optic neuropathy (NAION) in individuals with type 2 diabetes, according to a study published online Dec. 18 ...
Commonly described as an eye stroke, NAION occurs when the blood supply to the optic nerve is suddenly disrupted, causing ...
GLP-1 RAs are linked to an increased risk of NAION in type 2 diabetes patients, with semaglutide and liraglutide showing significant associations. The study involved over 3.8 million Medicare patients ...
Semaglutide is linked to a small but significantly elevated risk for nonarteritic anterior ischemic optic neuropathy (NAION), according to the results of a new study. The risk for NAION was ...
A retrospective cohort study suggested that users of GLP-1 receptor agonists had a 7% higher incidence of new-onset diabetic retinopathy. In patients with existing diabetic retinopathy, use of GLP-1 ...
Although only association and not causality can be inferred, this study showed that, among patients who had diabetes, an elevated risk of NAION was associated with semaglutide use compared with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results